Abstract
Background: Nowadays molecular modeling is widely used in different areas of scientific research. Especially in medical and pharmaceutical research molecular modeling allows saving time and money in conception of new drugs by comprehension of interaction between disease's enzymes and inhibitors for probable formation of stable complex. Cinnamon as famous plant and culinary spice is highly recommended in treatment of type 2 diabetes by many researchers.
Methods: By molecular modeling and molecular docking, interactions between type 2 diabetes enzyme (DPP-4) and characteristically molecules of cinnamon are studied.
Results: Molecules from different parts of cinnamon interact differently with diabetes type 2 enzyme (DPP-4) and confirm primary studies concerning cinnamon anti-diabetic effect.
Conclusion: Buds and flowers molecules of cinnamon inhibit DPP-4 enzyme better than barks commonly used as spices and traditional medicines.
Keywords: Cinnamon, diabetes, DPP4, inhibitor, MOE (Molecular Operating Environment), molecular modeling.
Graphical Abstract
Current Enzyme Inhibition
Title:Molecular Modeling Interaction Between Enzyme Diabetes Type 2 Dipeptidyl- Peptidase (DPP-4) and Main Compound of Cinnamon
Volume: 14 Issue: 1
Author(s): Bouchentouf Salim*, Ghalem Said, Missoum Noureddine and Allali Hocine
Affiliation:
- Laboratory of Naturals products and bioactives, University Aboubekr Belkaid of Tlemcen,Algeria
Keywords: Cinnamon, diabetes, DPP4, inhibitor, MOE (Molecular Operating Environment), molecular modeling.
Abstract: Background: Nowadays molecular modeling is widely used in different areas of scientific research. Especially in medical and pharmaceutical research molecular modeling allows saving time and money in conception of new drugs by comprehension of interaction between disease's enzymes and inhibitors for probable formation of stable complex. Cinnamon as famous plant and culinary spice is highly recommended in treatment of type 2 diabetes by many researchers.
Methods: By molecular modeling and molecular docking, interactions between type 2 diabetes enzyme (DPP-4) and characteristically molecules of cinnamon are studied.
Results: Molecules from different parts of cinnamon interact differently with diabetes type 2 enzyme (DPP-4) and confirm primary studies concerning cinnamon anti-diabetic effect.
Conclusion: Buds and flowers molecules of cinnamon inhibit DPP-4 enzyme better than barks commonly used as spices and traditional medicines.
Export Options
About this article
Cite this article as:
Salim Bouchentouf *, Said Ghalem, Noureddine Missoum and Hocine Allali, Molecular Modeling Interaction Between Enzyme Diabetes Type 2 Dipeptidyl- Peptidase (DPP-4) and Main Compound of Cinnamon, Current Enzyme Inhibition 2018; 14 (1) . https://dx.doi.org/10.2174/1573408013666170613103142
DOI https://dx.doi.org/10.2174/1573408013666170613103142 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Hot Topic: Hypertension: A Serious Complication in Pregnancy)
Current Hypertension Reviews Electrocardiographic and Cardiac Autonomic Indices - Implications of Sex-Specific Risk Stratification in Women After Acute Myocardial Infarction
Current Pharmaceutical Design Mechanisms of Hormonal Regulation of Sertoli Cell Development and Proliferation: A Key Process for Spermatogenesis
Current Molecular Pharmacology Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment
Current Pharmaceutical Design Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations
Current Pharmaceutical Biotechnology Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Phenolic Compounds as Antioxidants: Carbonic Anhydrase Isoenzymes Inhibitors
Mini-Reviews in Medicinal Chemistry Phyto-glycosides as Therapeutic Target in the Treatment of Diabetes
Mini-Reviews in Medicinal Chemistry Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
Recent Patents on Cardiovascular Drug Discovery Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Biochemical Markers of Bone Turnover and their Role in Osteoporosis Diagnosis: A Narrative Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) A Review of Intrahepatic Cholestasis of Pregnancy
Current Women`s Health Reviews Mesoporous Bioactive Glass Scaffold Delivers Salvianolic Acid B to Promote Bone Regeneration in a Rat Cranial Defect Model
Current Drug Delivery Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
Current Drug Safety 3D Printing Technology Over a Drug Delivery for Tissue Engineering
Current Pharmaceutical Design Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Current Pharmaceutical Design Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Current Vascular Pharmacology Type 1 Diabetes in Young Adulthood
Current Diabetes Reviews